-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
BC-11 hydrobromide
Category | SARS-CoV |
CAS | 443776-49-6 |
Description | BC 11 hydrobromide is a selective urokinase (uPA) inhibitor (IC50 = 8.2 μM) with no activity at 8 other related enzymes. BC 11 inhibits clot lysis displaying no effect on clot formation. It also decreases viability of MDA-MB231 breast cancer cells in vitro. |
Product Information
Synonyms | BC 11 hydrobromide;443776-49-6;BC-11 hydrobromide;BC11 hydrobromide;(4-((Carbamimidoylthio)methyl)phenyl)boronic acid hydrobromide;BC-11 (hydrobromide);uPA inhibitor BC-11 hydrobromide;GLXC-15931;AKOS024458122;DA-61527;HY-108447;CS-0028707;G82409;4-(Carbamimidoylthiomethyl)phenylboronic acid hydrobromide;[4-(carbamimidoylsulfanylmethyl)phenyl]boronic acid;hydrobromide;{4-[(Carbamimidoylsulfanyl)methyl]phenyl}boronic acid hydrobromide; |
IUPAC Name | [4-(carbamimidoylsulfanylmethyl)phenyl]boronic acid;hydrobromide |
Molecular Weight | 290.97 |
Molecular Formula | C8H12BBrN2O2S |
Canonical SMILES | NC(SCC1=CC=C(B(O)O)C=C1)=N.[H]Br |
InChI | InChI=1S/C8H11BN2O2S.BrH/c10-8(11)14-5-6-1-3-7(4-2-6)9(12)13;/h1-4,12-13H,5H2,(H3,10,11);1H |
InChIKey | PAFZAMOVHIRQOD-UHFFFAOYSA-N |
Appearance | Solid |
Storage | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |